Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer

Clinical and Translational Oncology

Volumn 15, Issue 10, 2013, Pages 849-854

  Wang, S ^a   Li, Q ^a   Wang, K ^b   Dai, Y ^c   Yang, J ^d   Xue, S ^a   Han, F ^a   Zhang, Q ^a   Liu, J ^a   Wu, W ^c  

^a BENGBU MEDICAL COLLEGE   (China)

^b Central South University   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bladder cancer; Clinicopathological characteristics; MicroRNA 31; Prognosis

Indexed keywords

MICRORNA 31; PIRARUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; DEATH; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84885171727     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1014-4     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Droller MJ (1998) Bladder cancer: state-of-the-art care. CA Cancer J Clin 48:269-284
3. Vaishampayan U (2009) Systemic therapy of advanced urothelial cancer. Curr Treat Options Oncol 10:256-266
4. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666-675
5. Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J et al (2003) Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Cancer 98:955-961
6. Khaled HM, Bahnassi AA, Zekri AR, Kassem HA, Mokhtar N (2003) Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 21:334-341
7. Dinney CP, McConkey DJ, Millikan RE (2004) Focus on bladder cancer. Cancer Cell 6:111-116
8. Wang M, Chu H, Li P, Yuan L, Fu G, Ma L et al (2012) Genetic variants in microRNAs predict bladder cancer risk and recurrence. Cancer Res 72:6173-6182
9. Williams MB, Liana A (2011) MicroRNAs in bladder cancer. In: Cho WCS (ed) MicroRNAs in cancer translational research. Springer, Netherlands, pp 223-237
10. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12:580-587
11. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S et al (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59:671-681
12. Song T, Xia W, Shao N, Zhang X, Wang C, Wu Y et al (2010) Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev 11:905-911
13. Valastyan S, Weinberg RA (2010) miR-31: a crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 9:2124-2129
14. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Lavoie AK et al (2011) A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 29:794-801. e1
15. Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H et al (2009) MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 124:2236-2242
16. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414
17. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105
18. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC et al (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032-1046
19. Bandre's E (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and nontumoral tissues. Mol Cancer 5:29
20. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J et al (2009) Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26:27-34
21. Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 16:360-364
22. Yan LX (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14:2348-2360
23. Zhang Y, Guo J, Li D, Xiao B, Miao Y, Jiang Z et al (2010) Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol 27:685-689
24. Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C et al (2011) A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 17:6802-6811
25. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L et al (2011) The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) 121:437-447
26. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M et al (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9:4387-4398
27. Xu RS, Wu XD, Zhang SQ, Li CF, Yang L, Li DD et al (2013) The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. Int J Oncol 42:676-682
28. Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA et al (2012) Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget 3:1011-1025
29. Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ et al (2013) Passenger strand miRNA miR-31(*) regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol 49:27-33